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The precise imeractions bcrwecn the subuni1s of G, (I%, p, y) and 1hc plasma membrane remain to be established. IT a, is associakd loosely with 
the inner membrane. is labile during activation, or is slways prcscn1 to some extent in the cytoplasm, then it should fractionate 10 the supcrnatant 
of a high-speed ccntrifugation. We identified abundant a, (Z-66% of tolal cellular) in the supcmatant fraction of right a1rial and left ventricular 
membrane preparations of porcine heart as shown by two distinct mcnsures 01’ a. (immunoblouing and ADP ribosylation by cholera toxin), 
However, functional assuys utilizing reconstitution ofcardiac a, with cyc- S49 membranes revealed that the supernutant fraction con1ained N 16% 
of total cellular a, activity. The cc, prcscnt in the suprrnatunt frac1ion did not result from contamination by sarcolemmul membrane fragmems. 
We conclude that tradi1ional methods for quantifying a, which utilize only dclurgent exlracts from high-speed pellets do 1101 account for a sizable 
proportion of total csllulnr a,. but that the majority of this population ofcardiac I, may no1 be functional, a1 least rvith rcspcri to adenylyl cyclusc 
ac1ivation. 
G-protein: Signal transduction: Myocardium: cyc” reconstitution: Immunoblo1ting: Cholera toxin; ADP-ribosylation 
1. INTRODUCTION 
The stimulatory guanine nuclcotide binding protein 
(G,) is comprised of three subunits: a, B and y. The 
stimulator-y a subunit (a,) transduces the activation 
signal between the G-linked receptors and adenylyl cy- 
clasc. The structural organization of a, (associated, he- 
terotrimeric form; or free, monomeric form) depends 
upon its functional state (GDP-and GTP-bound forms, 
respectively), and may reflect distinct modes of associa- 
tion of a, with the plasma membrane. In the GDP- 
bound form, a, appears to be bound tightly to the /?y 
dimer which may anchor the a subunit to the plasma 
membrane [I]. Stimulation by agonists of receptors that 
are coupled to G, induces exchange of GDP by GTP on 
a,. which promotes dissociation of the GTP-liganded 01, 
from pr [2]. The subsequent interactions of the acti- 
vated as monomer are not precisely known. In cardiac 
Abbrwicrrium: G-protein, guanine nucleotide-binding protein; G,, the 
G-protein that medirucs stimulation of adenylyl cyclasc (EC 4.6. I. I) 
a,, the a subunit of G,; By, the ,8 and y subunit dimer of G proteins; 
K*-pNPPase. K+-stimulated p-nitrophenyl phosphatase. 
Currcs/~ol&~cr uddrrss: D.A. Roth. Cardiovascular Division. M-01 3. 
J, University of California at San Diego. La Jolla, CA 91093. USA. 
Fax: (I) (Gl9) 534 7415. 
tissue, association of activated a, with the catalytic sub- 
unit of adenylyl cyclase generates CAMP, which leads 
to the cascade of intracellular events that enhance car- 
diac inotropy and chronotropy. 
Recent reports have shown that activated G,, or the 
cc, subunit alone, can regulate cardiac calcium channels 
both directly and indirectly (through activation of 
CAMP-dependent protein kinasej [3], Moreover, three 
splice variants of a, were shown to stimulate both ade- 
nylyl cyclasc and calcium channels [4]. Cardiac P-adre- 
nergic receptors also can inhibit Na’ channels through 
G, by both cytoplasmic (indirect) and membrane-de- 
limited (direct) pathways [S]. Hence, G, may act on at 
least three effecters in the heart vice plasma mcmbrane- 
associated, non-plasma membrane-associated, or com- 
binations of the two: adenylyl cyclase, calcium channels, 
and sodium channels. 
A variety of hormone and neurotransmitter receptors 
in heart [6,7] and other tissues [8,9] have been identified 
in intracellular pools associated with light vesicle frac- 
tions. Existence of cytosolic pools of Gi [ 10,l I] and G, 
[12] have also been suggested. We hypothesized that 
cardiac G, might have two forms: one firmly associated 
with the plasma membrane, and one present in the cyto- 
sol. If a, was associated loosely with the sarcolemma, 
was labile during activation, or was always present o 
some extent in the cytoplasm, then it should fractionate 
to the supernatant of a high-speed centrifugation. We 
provide evidence for such fractionation in the current 
studies. 
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2. EXPERIMENTAL 
[“*P]aATP (30 Ci/nunol), [“PINAD (800 Ci/mmol), rabbit anti-a, 
subunh antibodies, and [l?]probzin A(8.81 pCi/pg): DuPont/New 
England Nuclex(NEN, Boston MA, USA); [‘H]cAMP(30Ci/mmol): 
Amcrsham. UK: sodium cbolate: Calbiochem (La Jolla, CA, USA); 
electrophorcsis and SDS-PAGE rcagcnts: Bio-Rad (Richmond, CA, 
USA); cholera toxin and pcnussis toxin: List Biological Laboralorics 
(Campbell, CA, USA); all other rcagems: Sigma (SL Louis, MO, 
USA). 
2.2. Atdmuls. tihcc rolkcrh~ uttrl prqxtruriarr 
Five pigs (sus scruJa. 33 ? 23 kg) were used. Transmural samples 
of right atria1 (RA) and IelI ventricular (LV) free wall were rinsed free 
of blood and stored at -80°C. Samples were powdered in a stainless 
steel mortar and pestle. Three ml of phosphate buffer (IO mM 
KH,PO,, 5 mM MgCl,~H,O, 5 mM EDTAsNa, I mM EGTA. 50 
KIU/ml (kallikrcin inhibitory units) aprolinin, pH 7.5) were added IO 
40 mg of powdered sample and glass/glass homogenized (Kontes. 
Vineland, NJ, USA) on ice for -1 min (30 strokes), as previously 
described [L3.14]. No extraction of contractile proteins was employed 
unless indicated. Each sample then was ccntrifugcd (45 000 x g. 20 
min, 4°C). and supernatant (SUP) and pellet (PEL) fractions ob- 
lained. PEL fractions were rcsuspcnded up to I .5 ml in the same 
buffer, and an aliquot then was agitated with 1% purified sodium 
cholate for GO min on ice. This cholatc-treated pcllct fraction then was 
ccntrifugcd (20 000 x g. 30 min. 4”C), and the resulting supcrnatant 
fraction, termed cholate extract (EXT), and pellet fraction (remnant) 
wcrc obtained. Cardiac a, was s~dbilieed with 0.1 % Lubrol PX in the 
SUP and EXT fractions. Volume, protein concentration [Is]. and 
cxtraclion yield were calculated. Assays were performed on the indi- 
cated number of animals at least twice on the same preparations on 
ditrcrent experimcmal days. In some cxpcrimcnrs, fresh RA and LV 
tissue was homogen$td (2 x I5 s bursts on a Tcktnar Tissumizcr. 
20 500 rpm, 4°C) and analyzed side-by-side with the frozen 
preparation technique described above. 
2.3. Inlmunuhlotti~lg of curciiuc a,, ur~dp srrbutth of G,) 
Asscssmcnt of the a, subunit of G, was conducted using immuno- 
blotting with rabbit anti-a, subunit antibodies. Su~rnatani and cho- 
late-exu-acted protein (60 ,Q$ were elcctrophoresed, treated with di- 
luted anti-a, pcptidu antibody :! :600). and autoradiographed [l6]. The 
45 kDa band then was removed for gamma counling. Assessmcm of 
the p subunit of the cardiac G-protein in SUP and PEL was dctcr- 
mined as above by Wesiern blotting with rabbit anti-b subunit anti- 
bodies kindly providsd by Dr. G.M. Bokoch. Identified 35/36 kDa 
bands were rcmovcd for gamma counting. 
2.4. Cftohu toxin-und pertrrssi~ toxin-cutulyx~d A DP-rif~osylrrtiorr 
Assessment of G, and Gi by (cholera toxin and pertussis loxin, 
respectively) catalylred ADP-ribosylation was conducted on SUP and 
EXT fractions 117); the NAD concentration was increased to SpM to 
obtain maximal labeling. In quantifying cardiac a,. the 45 kDa bands 
were cut out and liquid scintillation countin& was employed, The 52 
kDa bands were observed inconsisuntly and only in the EXT, and 
thus were not included in calculations of total cellular activity. In 
quantifying G;, the doublet at 40 kDa and the thin band nt 33 kDa 
were cut OUL and counted as described above. Because the free ai 
monomer cannot be ADP-ribosylatLd, purified,+ was added to SUP 
and PEL fractions to detect monomeric a,. Purified B7 from porcine 
brain was kindly provided by Dr. T. Katada. Additional cxprimrnts 
using cholera toxin labelling of fresh right atrium and left ventricle, 
with and without ADP ribosylation fuclor (ARF) derived from mouse 
lymphoma 549 cyc- (G,-deficient), with and without 1% sodium cho- 
late were pcrrormcd to control I’or the possible dT.ec~s or sampie 
storage, ARF deprivation, and dctcrgcrn extraction. 
2.5. R~ronstirutiun of cyc- nronbrarrrs by cardiac a, 
SUP and EXT fractions were used to quanlify a, activity of RA tend 
LV samples, The capacity of these fractions to rcconstitutc a,-mcdia- 
ted (fluoride-stimulated) production of CAMP in membranes ,from 
a,-dclicient S49 murinc lymphoma cells (94,15.1, cyc-) srvcd as P 
funclional assay for LY. [I@!. Preliminary stud& showed CAMP pro. 
duction to be proportional to the amount of SUP and EXT added. and 
thai the rate of cAMP synthesis remained linear with time for 40 min. 
Total activity of the tissue is expressed in pmol CAMP produced/mg 
wet weight. 
2.6. Assrrys of .surcikmmaf nrmlbrutre rllurk~rs 
To dclcrminc if G, activity in SUP resulted from plasma membrane 
fragments rather than free a,, K’-pNPPase specific activity [PI] and 
forskolin-stimulated (100 PM) adenylyl cyclasc specific activity [20] 
wcrc used as markers for sarcolemmal mcmbranc. 
2.1. Midluiticui r&use of curdiuc 5, 
To assess if tissue disruption might cause reicase of a. from Ihc 
sarcolemma. Ihe effects of30, GO, or 120 s ofpolylron homogcnizalion 
(4°C. setting no. 5. Brinkman Instruments, Luzern Switzerland)on the 
rclcasc of a, wasdctermined by immunoblottingand by cholrra toxin- 
catalyzed ADP-ribosylation. 
recorded for preparations rised 
in this study, after calculation of total activity in a frac- 
tion, both the greater volume and proteiil content in the 
SUP fraction yielded a greater increase in total activity 
than in the EXT fraction. The sum of the total activity 
of these fractions yhen the entire PEL fraction was 
extracted was termed total tissue activity. 
Results from immunoblotting studies that were quan- 
tified by gamma counting (Fig. 2A) showed that in RA, 
52214% of total tissue activity was distributed to SUP, 
and 481-14% to EXT. The SUP from Lv contained 
S4k?%, and EXT contained 47-1-7% of total tissue a, 
activity. LV total tissue activity was 2.4-fold higher than 
RA total tissue activity (LV: 43911-993 cprn/mg wet 
weight; RA: 1,799?840 cpm/mg wet weight, P=0.004). 
Immunoblots of fresh and frozen preparations from the 
right atrium and left ventricle probed side-by-side 
showed similar bands in both supernatant and pellet 
fractions. 
3.2. Choleru foxin-mralyzed A LIP ribosykrrion 
Fig. i B shows 
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Western blot of purilled as and left venlricular 
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1 
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(cholate extract) (supernatant) 
B Cholera toxin-medlated ADP dbosylalian at left ventricular lractlons from one porcine heafl 
I- 45 kDa 
Fig. 1. Autoradiographs ofprepared fractions of porcine left ventricle. 
(A) Immunoblot of purified a, (45 kDa) and left ventricular (LV) 
fractions from 6 porcine hearts. Lanes 1-5 have indicated atnounts of 
purified a, added per well. Lanes 6-l I have 60~6 of cholate extracted 
protein (EXT) added per well. Lanes 12-I 7 have GO pug of supernatant 
protein (SUP) added per well. 0)) Autoradiograph of cholera toxin- 
mediated ADP ribosylation of four prepared fractions (pellet, cholatc 
extract, remnant, supernatant) from one porcine left ventricle. Each 
lane was loaded with l6yp of protein from the indicated fractions. See 
text for fraction definitions. 
However, after calculations taking into account the 
fraction volumes and protein content as described 
above, total tissue activity is distributed as seen in Fig. 
2B. Results from quantitative ribosylation studies (Fig. 
2Bj showed that in RA, 61 z! 10% of the total tissue 
activity was distributed to SUP, and 39-1-108 to EXT. 
The SUP from LV contained 6626% and EXT con- 
tained 34*6% of total tissue a, activity. Again, LV total 
tissue activity was more than 2.5-fold higher than RA 
(LV: 26.3f5.3 fmol/mg wet weight; RA: 10.4C2.7 fmol/ 
mg wet weight, P=O.O003). 
We performed additional experiments using cholera 
toxin labelling of fresh right atrium and left ventricle, 
with and without ARF derived from mouse lymphoma 
S49 cyc- (@,-deficientj, with and without 1% sodium 
cholate additions, and found identical results as report- 
ed above, with no effect of adding ARF, detergent, or 
using fresh tissue. 
B 
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Fig. 2. Asscssmunt of Gs activity in right atrial (RA: and left ventri- 
cular (LV) tissue by three methods. The ordinate is percent of total 
activity. Absolute activities arc expressed in indicated units above or 
below each bar for the respective tissues and fractions. (A) Results of 
quantitative immunoblots utiliiing rabbit anti-as antibodies and ‘% 
protein A in supernat3nt (SUP) _.. omd cholate exf.mct (EXT) frztions. 
(U) Results of quantitative cholera toxin-catalyzed ADP-ribosylation 
in supcrnatant SUP and EXT fractions. (C) Results of reconstitution 
assays utilizing S49 cyc- membranes with 10 mM NnF stimulation in 
the SUP and EXT fractions. 
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3.3. AecoltsliIution 
Fig. 2C shows the res;llts of reconstitution studies on 
SUP and EXT fractions from RA and LV. In RA, 
17+6% of the total tissue activity was found in SUP, and 
8356% in the EXT. Similar distributions were found in 
the LV (SUP: 1514%; EXT: 8511‘4%). it is noteworthy 
that LV had 3-fold more a, activity than the RA (LV: 
232251 pmoi CAMP produced/mg wet weight; RA: 
71 k-8 pm01 CAMP produced/mg wet weight: P < 
0.0001). In addition, when SUP, or sequential dilutions 
of SUP supplemented with heat-inactivated SUP (95”C, 
5 min) were reconstituted under the same conditions, a 
linear response of CAMP production was obtained 
(r=0.93, 11=4, data not shown). Reconstitution in cyc- 
membranes was not affected by 1% cholate treatment 
of SUP fractions. 
Fig. 3 shows that in LV, the specific activity of K+- 
pNPPase in SUP was only 9% of the total activity, 
demonstrating that supernatant as activity cannot be 
explained by membrane fragment contamination. Fors- 
kolin-stimulated adenylyl cyclase specific activity con- 
firmed these findings with only 3% of total adenyiyl 
cyclase activity present in supernatant. Additionally, 
the pertussis toxin-catalyzed labeling of the SUP was 
very low compared to the PEL in both heart chambers, 
indicating only minimal contamination by membrane 
fragments in this preparation. Moreover, detection of 
/3- subunit by Western blots with purified P-subunit an- 
tibodies in SUP was minimal compared to PEL frac- 
tions (data not shown). 
When the quantity of a, in SUP and PEL fractions 
of LV tissues was assessed for total a, content by both 
immunoblotting and cholera toxin-catalyzed ADP-ri- 
bosylation, we found that increased tissue disruption 
(30, 60 or 120 s of polytron homogenization) did not 
yield increased release of er, to supernatant (data not 
shown), suggesting that the above findings cannot be 
explained by mechanical disruption alone. We are un- 
Fig. 3. Specific activity of two sarcolemmal membrnnc markers used 
to determine mcmbtanc content of’ supcmatant (SUP) and pullet 
(PEL) fractions of Mt ventricle (LV). #+-stimulated p_NPPasc specific 
activity (nmol/m& provzinhour, left panel) wd forskolin-stimulotcd 
adenylyl cyclue specific achity (pmol/mg protcin/min. right panel). 
able to determine whether ‘basal’ levcis of a6 release 
result from mechanical disruption; there may bc a vul- 
nerable or loosely-associated population of a, that ac- 
counts for this distribution. Nevertheless, we show this 
to be an important population of a, when trying to 
quantify total 01,, and speculate that it may be a biologi- 
cally important fraction. We employed the present sc- 
dimentation conditions to match those routinely 
reported in the literature, but we also found that the a, 
activity in SUP was similar whether 45000 x g or 
180 000 x g centrifugations were employed. 
Contractile protein extractions with high ionic 
strength solutions are used commonly when studying 
cardiac tissue in an attempt to obtain sarcolemmal 
membranes of higher purity for biochemical analyses 
[13,14]. We found similar amounts of a, activity in SUP 
fractions whether or not crude cardiac membranes were 
extracted with 0.5 M KCI, implying that supernatant a, 
is not due to the labile release of a, from the cytoplasmic 
face of the plasma membrane. If initially a low-speed 
centrifugation (1250 x g) was employed to pellet con- 
tractile proteins and nuclei from crude homogenate [21], 
followed by 45,000 x g centrifugation of the SUP, we 
found a loss of 72% of total tissue a, activity (assessed 
by ADP-ribosylation) to the routinely discarded pellet 
of the 1250 x g centrifugalion. in addition, after 1% 
cholate extraction of PEL and subsequent centrifuga- 
tion, about 36% of total a, activity remained in the 
routinely discarded remnant fraction, a consistent lind- 
ing whether or not an initial low-speed centrifugation 
was employed (data not shown). 
4. DISCUSSION 
When we assessed cc, by immunoblotting and cholera 
toxin-catalyzed ADP ribosylation, we found that a size- 
ble proportion (52-668) of total tissue a, is discarded 
in the SUP fractions from routine preparations 0r myo- 
cardial tissue. This a, activity does not result from mem- 
brane contamination of the supernatant during tissue 
preparation, and is not affected by either high salt trcat- 
meat or initial low-speed centrifugation of a crude car- 
diac homogenate. Conversely, reconstitution of cardiac 
a, with cyc- S49 cell membranes yielded a much smaller 
proportion of functional a, activity to the SUP (I 6%), 
where the majority of biologically active a, was present 
in the EXT (84%). 
The current findings have both methodological and, 
potentially, broad biological implications. Because a 
substantial proportion of cardiac a, protein is discarded 
during routine membrane preparations, our results call 
into question the meaning of reported changes in as 
from studies in which only a fraction of total a, may 
have been measured. Future studies will need to provide 
more detailed quantitative accounting of a,. 
The biological implications of our findings are impor- 
tant, for they suggest that a, may not only be dedicated 
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to plasma membrane-associated interactions, but may 
also have as yet unknown functions within the cell. The 
biological activity of this !arge population of a, as a 
stimulator of adenylyl cyclase may be low as assessed 
by reconstitution (Fig. 2C), implying that the SUP may 
lack an essential cofactor for adenylyl cyclase activa- 
tion, or that there has been a covalent or proteolytic 
modification of Q, such that effector coupling or activa- 
tion is diminished even though mobility in SDS-PAGE 
is unaltered. We do not know if this a, population is 
functional as a stimulator of other effecters. Using the 
reconstitution data to assess the function of the a, in 
SUP and EXT fractions of the LV, and data from cho- 
lera toxin-mediated ADP ribosylotion to quantify 
pmols of a, in the two fractions, we calculate that the 
turnover rate in the EXT is more than l4-fold greater 
than that in the SUP (594fl20 vs 3952 pmol CAMP/ 
min/pmol a,: P c 0.001). 
In theory, the origin of the as population in the SUP 
fraction might be from intracellular pools associated 
with structures where the protein is synthesized, modi- 
fied, and transported to the plasma membrane [23,241. 
However. the high proportion of a, we detect in the 
supernatant fractions, whether functional or not, is un- 
likely to be fully accounted for by those pools, and is 
not accounted for by plasma membrane contamination 
(Fig. 3). Alternatively, a, in the supematant fraction 
may represent a population of a, normally present in the 
cytosol and associated with light vesicle fractions 
[24,25], pinocytotic vesicles [lo], or may be a conse- 
quence- of disengagement of membrane-bound G, from 
the sarcolemma [5,2G], Perhaps during activation by 
hormones or neurotransmitters, a, dissociates from the 
cytoplasmic face of the plasma membrane and becomes 
soluble in the cytoplasm, available to interact with 
membrane-bound effecters such as enzymes or ion 
channels [3-51, with intracellular organelles [22.23,27], 
or to remain in equilibrium as a labile pool of a, 
[5,10,24,26]. 
We have provided evidence for two pools of G, in the 
heart: plasma membrane-associated and non-plasma 
membrane-associated. Data suggesting non-plasma 
membrane-associated pools of a, have been reported for 
several culture cell lines [l 1,22,243, but previous results 
have not shown that such pools exist in tissues irz vim. 
However, previous data have indicated that the heart 
and other cell types possess G, in substantial excess of 
receptors. Moreover, G, may interact with more than 
one effector [4,28], so that this supernatant population 
of as may integrate the input from several receptors, and 
may be a branch point for regulation of multiple effec- 
tors in response to a single signal. Since individual re- 
ceptors are catalytic in activation of multiple G, mole- 
cuies &i4,2Sj, ihC current findings arc consistent with 
the intriguing speculation that activation of G, by 
agonists can program a, molecules to perform multiple 
functions in target cells [27]. 
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